Kristine Yaffe

<table class="infobox infobox-researcher">
<tr>
<th class="infobox-header" colspan="2">Kristine Yaffe</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>Photo placeholder</em>
</td>
</tr>
<tr>
<td class="label">Affiliations</td>
<td>University of California San Francisco</td>
</tr>
<tr>
<td class="label">Country</td>
<td>USA</td>
</tr>
<tr>
<td class="label">H-index</td>
<td>200</td>
</tr>
<tr>
<td class="label">ORCID</td>
<td><a href="https://orcid.org/0000-0001-9785-9923" target="_blank">0000-0001-9785-9923</a></td>
</tr>
<tr>
<td class="label">Research Focus</td>
<td>[Alzheimer's Disease](/diseases/alzheimers), Cognitive decline</td>
</tr>
<tr>
<td class="label">Mechanisms</td>
<td>Risk factors, Prevention, [Sleep](/mechanisms/sleep-disruption-ad)</td>
</tr>
</table>

Kristine Yaffe

Overview

Kristine Yaffe is a leading researcher in the field of neurodegenerative diseases, affiliated with University of California San Francisco. Their research focuses on Risk factors, Prevention, Sleep, with particular emphasis on Alzheimer's Disease and Cognitive decline. With an h-index of 200, Yaffe is among the most cited researchers in the neuroscience field[@orcid2026].

<table class="infobox infobox-researcher">
<tr>
<th class="infobox-header" colspan="2">Kristine Yaffe</th>
</tr>
<tr>
<td class="infobox-image" colspan="2">
<em>Photo placeholder</em>
</td>
</tr>
<tr>
<td class="label">Affiliations</td>
<td>University of California San Francisco</td>
</tr>
<tr>
<td class="label">Country</td>
<td>USA</td>
</tr>
<tr>
<td class="label">H-index</td>
<td>200</td>
</tr>
<tr>
<td class="label">ORCID</td>
<td><a href="https://orcid.org/0000-0001-9785-9923" target="_blank">0000-0001-9785-9923</a></td>
</tr>
<tr>
<td class="label">Research Focus</td>
<td>[Alzheimer's Disease](/diseases/alzheimers), Cognitive decline</td>
</tr>
<tr>
<td class="label">Mechanisms</td>
<td>Risk factors, Prevention, [Sleep](/mechanisms/sleep-disruption-ad)</td>
</tr>
</table>

Kristine Yaffe

Overview

Kristine Yaffe is a leading researcher in the field of neurodegenerative diseases, affiliated with University of California San Francisco. Their research focuses on Risk factors, Prevention, Sleep, with particular emphasis on Alzheimer's Disease and Cognitive decline. With an h-index of 200, Yaffe is among the most cited researchers in the neuroscience field[@orcid2026].

Yaffe's work spans multiple aspects of neurodegeneration, contributing to our understanding of the molecular mechanisms that underlie diseases such as Alzheimer's Disease and Cognitive decline. Their research group has made significant contributions to the fields of Risk factors, Prevention, Sleep, publishing in high-impact journals including leading neuroscience journals.

Based at University of California San Francisco, Yaffe collaborates with researchers across multiple institutions worldwide, working to advance therapeutic strategies for neurodegenerative conditions.

Research Focus

Disease Areas

• [Alzheimer's Disease](/diseases/alzheimers-disease)
• Cognitive decline

Mechanisms of Interest

• Risk factors
• Prevention
• Sleep

Programmatic Emphasis

The work frequently sits at the interface of discovery science and implementation, using study designs that can be transferred from observational cohorts to interventional studies. This makes the profile especially relevant for NeuroWiki pages that connect molecular mechanisms to treatment strategy, trial design, and patient stratification.

Methods and Data Strategy

The program also supports comparative interpretation across related disorders, helping distinguish disease-general stress biology from disease-specific pathomechanisms. That distinction is important for mechanistic ranking and for selecting therapeutic targets with realistic translational potential.

Translational Relevance

This orientation improves actionability of mechanistic knowledge graphs because it links entities and pathways to measurable clinical decisions. Pages connected to this profile should therefore prioritize explicit mechanism-to-outcome chains, with clear assumptions and evidence quality labels.

Key Publications

Collaborators and Research Network

David M. Holtzman, Reisa A. Sperling

Institutional Context

Open Questions and Future Directions

• How can Risk factors, Prevention, Sleep signals be standardized across cohorts and sites without losing disease-stage sensitivity?
• Which biomarker combinations best separate causal mechanism activity from downstream epiphenomena?
• What trial designs can most efficiently translate mechanistic findings in Alzheimer's Disease and Cognitive decline into clinically meaningful interventions?

External Links

• ORCID: [https://orcid.org/0000-0001-9785-9923](https://orcid.org/0000-0001-9785-9923)
• Google Scholar: [Search for Kristine Yaffe](https://scholar.google.com/scholar?q=author%3A%22Kristine+Yaffe%22)
• PubMed: [Author search for Kristine Yaffe](https://pubmed.ncbi.nlm.nih.gov/?term=Kristine+Yaffe%5BAuthor%5D)

See Also

• [Researchers and Institutions Index](/researchers)
• [Diseases Index](/diseases)
• [Mechanisms Index](/mechanisms)

Recent Research (2024-2026)

References